# Using team-based precision medicine to advance understanding of rare genetic brain disorders

**Authors:** Steven U. Walkley, Sophie Molholm, Bryen Jordan, Robert W. Marion, Melissa Wasserstein

PMC · DOI: 10.1186/s11689-024-09518-z · 2024-03-15

## TL;DR

A team-based approach connects families with rare genetic brain disorders to scientists and doctors, fostering collaboration and new insights into these conditions.

## Contribution

A novel multidisciplinary teamwork model for rare genetic brain disorders that integrates families, physicians, and scientists.

## Key findings

- Team meetings led to families establishing foundations for specific conditions and increased scientist engagement with relevant gene variants.
- Collaborations expanded nationally and internationally, highlighting rare diseases as gateways to broader biological understanding.
- The approach empowered families and broadened scientists' perspectives on the real-world impact of their research.

## Abstract

We describe a multidisciplinary teamwork approach known as “Operation IDD Gene Team” developed by the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK IDDRC) at the Albert Einstein College of Medicine. This initiative brings families affected by rare genetic diseases that cause intellectual and developmental disability together with physicians, basic scientists, and their trainees. At team meetings, family members share their child’s medical and personal history, physicians describe the broader clinical consequences of the condition, and scientists provide accessible tutorials focused on the fundamental biology of relevant genes. When appropriate, possible treatment approaches are also discussed. The outcomes of team meetings have been overwhelmingly positive, with families not only expressing deep gratitude, but also becoming empowered to establish foundations dedicated to their child’s specific condition. Physicians, and in particular the scientists and their trainees, have gained a deeper understanding of challenges faced by affected families, broadening their perspective on how their research can extend beyond the laboratory. Remarkably, research by the scientists following the Gene Team meetings have often included focus on the actual gene variants exhibited by the participating children. As these investigations progress and newly created foundations expand their efforts, national as well as international collaborations are forged. These developments emphasize the importance of rare diseases as windows into previously unexplored molecular and cellular processes, which can offer fresh insights into both normal function as well as more common diseases. Elucidating the mechanisms of and treatments for rare and ultra-rare diseases thus has benefits for all involved—families, physicians, and scientists and their trainees, as well as the broader medical community. While the RFK IDDRC’s Operation IDD Gene Team program has focused on intellectual disabilities affecting children, we believe it has the potential to be applied to rare genetic diseases impacting individuals of any age and encompassing a wide variety of developmental disorders affecting multiple organ systems.

## Full-text entities

- **Diseases:** -rare diseases (MESH:D035583), genetic diseases (MESH:D030342), developmental disorders (MESH:D002658), Intellectual and Developmental Disabilities (MESH:D008607), brain disorders (MESH:D001927)

---
Source: https://tomesphere.com/paper/PMC10941544